Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05540002 · ClinicalTrials.gov registry record · NA
Efficacy of the Quell Wearable Device for Chronic Overlapping Pain Conditions
A NA study, sponsored by Brigham and Women's Hospital.
- Completed
- Registry status
- NA
- Development phase
- 115
- Enrollment target
NCT05540002 is a NA study that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 115 participants.
The verdict
NCT05540002, a NA study, has completed, sponsored by Brigham and Women's Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 115 participants
- Enrollment target
Study Summary
This study will examine the pain-relieving effects of a transcutaneous electrical nerve stimulator device called a Quell for persons with multiple chronic overlapping pain conditions.
Interventions
- DEVICE High Intensity Quell
- DEVICE Low Intensity Quell
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 115 participants |
| Start Date | 2022-10-14 |
| Est. Completion | 2024-09-19 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05540002
The ClinicalTrials.gov registry entry for NCT05540002 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 115 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Brigham and Women's Hospital, which has 937 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which High Intensity Quell is the first listed.
NCT05540002 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05540002 about?
NCT05540002 is a clinical study titled "Efficacy of the Quell Wearable Device for Chronic Overlapping Pain Conditions". This study will examine the pain-relieving effects of a transcutaneous electrical nerve stimulator device called a Quell for persons with multiple chronic overlapping pain conditions.
What is the current status of trial NCT05540002?
This trial is currently completed. It is a NA study. The enrollment target is 115 participants. The study started on 2022-10-14. Estimated completion is 2024-09-19.
What interventions are being tested in trial NCT05540002?
The interventions under investigation include: High Intensity Quell (DEVICE), Low Intensity Quell (DEVICE).
Who is sponsoring clinical trial NCT05540002?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.